Cargando…

Association between changes in bodyweight and cardiovascular disease risk factors among obese Japanese patients with type 2 diabetes

AIMS/INTRODUCTION: We aimed to assess the association between bodyweight reduction and cardiovascular disease risk factors, and to identify the minimum bodyweight reduction associated with significant improvement in cardiovascular disease risk factors among obese Japanese patients with type 2 diabet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshimura, Ran, Nakagami, Tomoko, Hasegawa, Yukiko, Oya, Junko, Babazono, Tetsuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434567/ https://www.ncbi.nlm.nih.gov/pubmed/35417613 http://dx.doi.org/10.1111/jdi.13809

Ejemplares similares

Comparative clinical outcomes of insulin degludec and insulin glargine 300 U/mL after switching from other basal insulins in real‐world patients with type 1 and type 2 diabetes
por: Oya, Junko, et al.
Publicado: (2021)

Association of birthweight with diabetes and insulin sensitivity or secretion in the Japanese general population
por: Oya, Junko, et al.
Publicado: (2015)

The combination of dulaglutide and biguanide reduced bodyweight in Japanese patients with type 2 diabetes
por: Inagaki, Nobuya, et al.
Publicado: (2016)

Association Between Lung Function and Metabolic Syndrome Independent of Insulin in Japanese Men and Women
por: Yamamoto, Yayoi, et al.
Publicado: (2014)

Comparison of three α‐glucosidase inhibitors for glycemic control and bodyweight reduction in Japanese patients with obese type 2 diabetes
por: Sugihara, Hitoshi, et al.
Publicado: (2013)

Effect of mild exercise on glycemic and bodyweight control in Japanese type 2 diabetes patients: A retrospective analysis
por: Nakanishi, Shuhei, et al.
Publicado: (2018)

Bodyweight change and cognitive performance in the older population
por: Kronschnabl, Judith M., et al.
Publicado: (2021)

Aging-like physiological changes in the skin of Japanese obese diabetic patients
por: Ibuki, Ai, et al.
Publicado: (2018)

Fluctuations in HbA1c are associated with a higher incidence of cardiovascular disease in Japanese patients with type 2 diabetes
por: Bouchi, Ryotaro, et al.
Publicado: (2011)

Association between 1-year changes in urinary albumin-to-creatinine ratio and kidney disease progression in Japanese individuals with diabetes: a historical cohort study
por: Babazono, Tetsuya, et al.
Publicado: (2023)

Unstable bodyweight and incident type 2 diabetes mellitus: A meta‐analysis
por: Kodama, Satoru, et al.
Publicado: (2017)

Restoration of perivascular adipose tissue function in diet‐induced obese mice without changing bodyweight
por: Xia, Ning, et al.
Publicado: (2017)

Lifestyle changes as a result of COVID‐19 containment measures: Bodyweight and glycemic control in patients with diabetes in the Japanese declaration of a state of emergency
por: Tanaka, Nagaaki, et al.
Publicado: (2021)

Blood glucose levels and bodyweight change after dapagliflozin administration
por: Kim, Hyunah, et al.
Publicado: (2021)

Ipragliflozin, a sodium–glucose cotransporter 2 inhibitor, reduces bodyweight and fat mass, but not muscle mass, in Japanese type 2 diabetes patients treated with insulin: A randomized clinical trial
por: Inoue, Hideka, et al.
Publicado: (2019)

Impact of physical activity and bodyweight on health-related quality of life in people with type 2 diabetes
por: Eckert, Katharina
Publicado: (2012)

Bodyweight Assessment of Enamelin Null Mice
por: Chan, Albert H.-L., et al.
Publicado: (2013)

COVID-19 and the Change in Lifestyle: Bodyweight, Time Allocation, and Food Choices
por: Li, Xiaolei, et al.
Publicado: (2021)

Effect of migrant parents' bodyweight perception on children's body bodyweight: A longitudinal analysis of population cohort study
por: Hartono, Susan, et al.
Publicado: (2022)

Bodyweight threshold for sudden onset of ketosis might exist in ketosis‐prone type 2 diabetes patients
por: Satomura, Atsushi, et al.
Publicado: (2019)

Association of dietary pattern with biochemical blood profiles and bodyweight among adults with Type 2 diabetes mellitus in Tehran, Iran
por: Darani Zad, Nasrin, et al.
Publicado: (2015)

A Single Nucleotide Polymorphism in KCNQ1 Is Associated With Susceptibility to Diabetic Nephropathy in Japanese Subjects With Type 2 Diabetes
por: Ohshige, Toshihiko, et al.
Publicado: (2010)

Could there be a fine-tuning role for brain-derived adipokines in the regulation of bodyweight and prevention of obesity?
por: Brown, Russell E.
Publicado: (2008)

Lower-limb muscle strength according to bodyweight and muscle mass among middle age patients with type 2 diabetes without diabetic neuropathy
por: Asada, Fuminari, et al.
Publicado: (2017)

High prevalence of depressive symptoms among people with pediatric‐onset and adolescent‐onset type 1 diabetes: A cross‐sectional analysis of the Diabetes Study from the Center of Tokyo Women's Medical University
por: Takaike, Hiroko, et al.
Publicado: (2022)

Bodyweight Changes Are Associated with Reduced Health Related Quality of Life: The Hordaland Health Study
por: Hervik Thorbjørnsen, Gunhild, et al.
Publicado: (2014)

Bodyweight change and its association with food and beverage consumption at the beginning COVID-19 confinement
por: Cavagnari, Brian M., et al.
Publicado: (2022)

Improved glycemic control and reduced bodyweight with exenatide: A double‐blind, randomized, phase 3 study in Japanese patients with suboptimally controlled type 2 diabetes over 24 weeks
por: Kadowaki, Takashi, et al.
Publicado: (2010)

Poor Eating Behaviors Related to the Progression of Prediabetes in a Japanese Population: An Open Cohort Study
por: Otsuka, Yuichiro, et al.
Publicado: (2022)

HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
por: Swerdlow, Daniel I, et al.
Publicado: (2015)

Pulse-contour derived cardiac output measurements in morbid obesity: influence of actual, ideal and adjusted bodyweight
por: Boly, Chantal A., et al.
Publicado: (2017)

Is Nigella sativa an Effective Bodyweight Lowering Agent and a Mitigator of Obesity Risk? A Literature Review
por: Al Asoom, Lubna
Publicado: (2022)

CREDENCE: A silver lining in the dark cloud of diabetic nephropathy
por: Hanai, Ko, et al.
Publicado: (2019)

Association between single nucleotide polymorphisms within genes encoding sirtuin families and diabetic nephropathy in Japanese subjects with type 2 diabetes
por: Maeda, Shiro, et al.
Publicado: (2011)

The Influence of a Single Nucleotide Polymorphism within CNDP1 on Susceptibility to Diabetic Nephropathy in Japanese Women with Type 2 Diabetes
por: Kurashige, Mahiro, et al.
Publicado: (2013)

Relationship between hemoglobin A1c and cardiovascular disease in mild-to-moderate hypercholesterolemic Japanese individuals: subanalysis of a large-scale randomized controlled trial
por: Nishimura, Rimei, et al.
Publicado: (2011)

Obesity as an effect modifier of the association between leptin and diabetic kidney disease
por: Hanai, Ko, et al.
Publicado: (2013)

Frequency of consumption of balanced meals, bodyweight gain and incident risk of glucose intolerance in Japanese men and women: A cohort study
por: Sakurai, Masaru, et al.
Publicado: (2020)

Patterns of Bodyweight Changes in Patients With Hypothyroidism, a Retrospective Study From Basrah, Southern Iraq
por: Alidrisi, Haider A, et al.
Publicado: (2021)

Acute Cholesterol-Lowering Effect of Exendin-4 inLdlr(−/−) and C57BL/6J Mice
por: Hori, Mika, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_prnukiksf0bsgbapj6f1hpouba